UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Engineering of human induced pluripotent stem cells via human artificial chromosome vectors for cell therapy and disease modeling

Kazuki, Y; Uno, N; Abe, S; Kajitani, N; Kazuki, K; Yakura, Y; Sawada, C; ... Tomizuka, K; + view all (2021) Engineering of human induced pluripotent stem cells via human artificial chromosome vectors for cell therapy and disease modeling. Molecular Therapy: Nucleic Acids , 23 pp. 629-639. 10.1016/j.omtn.2020.12.012. Green open access

[thumbnail of Engineering of human induced pluripotent stem cells via human artificial chromosome vectors for cell therapy and disease mod.pdf]
Preview
Text
Engineering of human induced pluripotent stem cells via human artificial chromosome vectors for cell therapy and disease mod.pdf - Published Version

Download (1MB) | Preview

Abstract

Genetic engineering of induced pluripotent stem cells (iPSCs) holds great promise for gene and cell therapy as well as drug discovery. However, there are potential concerns regarding the safety and control of gene expression using conventional vectors such as viruses and plasmids. Although human artificial chromosome (HAC) vectors have several advantages as a gene delivery vector, including stable episomal maintenance and the ability to carry large gene inserts, the full potential of HAC transfer into iPSCs still needs to be explored. Here, we provide evidence of a HAC transfer into human iPSCs by microcell-mediated chromosome transfer via measles virus envelope proteins for various applications, including gene and cell therapy, establishment of versatile human iPSCs capable of gene loading and differentiation into T cells, and disease modeling for aneuploidy syndrome. Thus, engineering of human iPSCs via desired HAC vectors is expected to be widely applied in biomedical research.

Type: Article
Title: Engineering of human induced pluripotent stem cells via human artificial chromosome vectors for cell therapy and disease modeling
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.omtn.2020.12.012
Publisher version: https://doi.org/10.1016/j.omtn.2020.12.012
Language: English
Additional information: Copyright © 2020 The Authors. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: DMD, MV-MMCT, T-iPSC, aneuploidy syndrome, gene and cell therapy, human artificial chromosome
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > Div of Biosciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > Div of Biosciences > Cell and Developmental Biology
URI: https://discovery.ucl.ac.uk/id/eprint/10122079
Downloads since deposit
45Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item